在PCV13被PCV10替换后,肺炎球菌血清型流行病学和耐药性,瑞典,瑞典
Linda Yamba Yamba1, Fabian Uddén2, Silvana Dalence3
1Clinical Microbiology, Department of Translational Medicine, Faculty of Medicine, Lund University, Inga Marie Nilssons gata 53, Wallenberg laboratoriet, SE21428 Malmö, Sweden; Clinical Microbiology, Infection Control and Prevention, Laboratory Medicine Skåne, Sölvegatan 23B, SE22185 Lund, Sweden.
The Journal of infection
|March 14, 2026
概括
瑞典 瑞典 瑞典 瑞典
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 公共卫生 公共卫生
背景情况:
- 瑞典在2018年在其儿童免疫计划中从PCV13过渡到PCV10.
- 这次转换旨在重新评估对Streptococcus pneumoniae血清型分布的影响.
研究的目的:
- 评估PCV13转为PCV10疫苗对瑞典肺炎球菌血清型分布的影响.
- 为了监测血清型流行率和抗菌素耐药性模式的变化,疫苗后的政策变化.
主要方法:
- 对1,615个呼吸道 (RT) 菌株 (Streptococcus pneumoniae) 隔离物 (2020-2023) 进行血清定型和抗菌素敏感性的分析.
- 与397个侵入性肺炎球菌病 (IPD) 隔离物和PCV13时代 (2016-2018) 的历史数据进行比较.
主要成果:
- 血清型3和19A在PCV10重新引入后在RT分离物中重新出现,占主导地位 (p<0.001).
- 血清型19A在IPD病例中也显著增加 (p<0.001).
- 在11%的RT分离物体中发现了减少的zylpenicillin敏感性,多药耐药性主要存在于15A和19A血清型中.
结论:
- 重新引入PCV10导致3和19A血清型的复苏.
- 持续监测至关重要,突出显示了快速用低价值疫苗替代血清型的风险.
相关概念视频
Pneumonia II: Pathophysiology
3.8K
The pathophysiology of pneumonia involves the following steps:
3.8K
Pneumonia III: Complications and Assessment
1.1K
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.1K
Pneumonia I: Introduction
1.2K
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.2K
Pneumonia V: Nursing management and Prevention
3.9K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.9K
Pneumonia IV: Management
1.0K
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.0K


